Grünenthal returns to debt markets for revolver after HY bond debut

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Grünenthal returns to debt markets for revolver after HY bond debut

pills adobe stock 575x375 pharmaceuticals
Heap of medical pills in white, blue and other colors. Pills in plastic package. Panoramic banner for design. | OKSANA KAZYKINA/okskaz - stock.adobe.com

Grünenthal, the German opioid maker, has signed a €400m revolving credit facility, less than a month after making its postponed debut in the high yield bond market.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article